CompoAtlas

Elvitaal B-STRESS Complex (2020.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000175/2020
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
SIA ''Mani Vitamīni''
Manufacturer
name not reproduced (no recognised company form)
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
1 tablete dienā
Published pack size
tabletes pa 922 mg
Published packaging
90 vai 180 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
B1 VITAMĪNSvitamins ; B1 VITAMĪNS ; 25 ; mgVitamine B1 (thiamine)Vitamin or mineral
B2 VITAMĪNSvitamins ; B2 VITAMĪNS ; 25 ; mgVitamine B2 (riboflavine)Vitamin or mineral
NIACĪNSvitamins ; NIACĪNS ; 20 ; mg NEVitamine B3 (niacine)Vitamin or mineral
PANTOTĒNSKĀBEvitamins ; PANTOTĒNSKĀBE ; 20 ; mgAcide pantothénique (vitamine B5)Vitamin or mineral
B6 VITAMĪNSvitamins ; B6 VITAMĪNS ; 10 ; mgVitamine B6Vitamin or mineral
B12 VITAMĪNSvitamins ; B12 VITAMĪNS ; 20 ; μgVitamine B12Vitamin or mineral
FOLSKĀBEvitamins ; FOLSKĀBE ; 30 ; μgFolates (vitamine B9)Vitamin or mineral
BIOTĪNSvitamins ; BIOTĪNS ; 20 ; μgBiotine (vitamine B8)Vitamin or mineral
Kalcijsminerals ; Kalcijs ; 25 ; mgCalciumVitamin or mineral
Magnijsminerals ; Magnijs ; 75 ; mgMagnésiumVitamin or mineral
Apiņu augļkopu pulverisplants ; Apiņu augļkopu pulveris ; Humulus lupulus ; 25 ; mghumulus lupulusPlant
Pasifloras lakstu pulverisplants ; Pasifloras lakstu pulveris ; Passiflora incarnata ; 25 ; mgpassiflora incarnataPlant
Kalifornijas magones virszemes daļas pulverisplants ; Kalifornijas magones virszemes daļas pulveris ; Eschscholtzia californica ; 25 ; mgNot recognisedRole not identified
Baldriāna saknes ekstrakts 4:1plants ; Baldriāna saknes ekstrakts 4:1 ; Valerianae officinalis ; 25 ; mgNot recognisedRole not identified
Mikrokristāliskā celuloze (E460i)otherIngredients ; Mikrokristāliskā celuloze (E460i)Not recognisedRole not identified
ParaaminobenzoiskābeotherIngredients ; Paraaminobenzoiskābe ; 20 ; mgNot recognisedRole not identified
HolīnsotherIngredients ; Holīns ; 20 ; mgNot recognisedRole not identified
InozītsotherIngredients ; Inozīts ; 20 ; mgNot recognisedRole not identified
Taukskābju magnija sāļi (E470b)otherIngredients ; Taukskābju magnija sāļi (E470b)Not recognisedRole not identified
Silīcija dioksīds (E551)otherIngredients ; Silīcija dioksīds (E551)Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Nīderlande

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Apiņu augļkopu pulveris
    Read the warning, when it applies and the studies cited

    HOPS - HUMULUS LUPULUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Sleep aid.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia) (Berardi et al. 2002; Dipiro et al. 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Other uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Mills and Bone 2005; McGuffin et al. 1997).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid taking with alcohol or products that cause drowsiness (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as this product may cause drowsiness (EMA 2014).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 April 2024

  • Pasifloras lakstu pulveris
    Read the warning, when it applies and the studies cited

    PASSIONFLOWER -PASSIFLORA INCARNATA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Sleep aid.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2014).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line